02/27/2025
3:31 PM | Verona Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
7:46 AM | Verona Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
5:07 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
5:43 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Verona Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
3:30 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
7:33 PM | Growth Equity Opportunities Fund IV, LLC (Filed by)
Verona Pharma (Subject)
| Form SCHEDULE 13D/A | |
01/07/2025
5:00 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
4:50 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
4:51 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
6:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VRNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Verona Pharma and its competitors with MarketBeat's FREE daily newsletter. |
11/26/2024
5:35 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
5:36 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
5:34 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:42 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:20 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
3:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
3:31 PM | Verona Pharma (Subject)
| Form SC 13G | |
11/14/2024
8:47 AM | Deep Track Capital, LP (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/13/2024
7:46 PM | Verona Pharma (Subject)
VIVO VENTURES VII, LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:57 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/07/2024
5:56 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:57 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:40 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:41 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
7:47 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
5:06 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:13 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:14 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:17 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:55 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:54 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:45 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:46 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:20 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:22 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:22 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) Tesla doesn't pay a traditional dividend....
But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla…
Which could put up to $7,013 in your pocket every month… Click here to discover the new #1 way to invest in Tesla |
08/28/2024
8:51 PM | Growth Equity Opportunities Fund IV, LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13D/A | |
08/12/2024
3:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:20 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
6:11 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:12 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:13 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:44 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:51 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
8:28 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:29 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:30 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2024
8:43 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G | |
06/27/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:53 AM | Verona Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024
8:09 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:22 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:18 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:21 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:15 PM | Brady James Aloysius (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:16 PM | Cunningham Kenneth (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | SHAH MAHENDRA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Ullman Anders (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:18 PM | Sinha Vikas (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024
7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024
6:45 PM | Gupta Rishi (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024
8:40 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
7:15 PM | ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free VRNA Stock Alerts